Effects of anesthetic agents on inflammation in Caco-2, HK-2 and HepG2 cells

被引:2
|
作者
Li, Weijing [1 ]
Hao, Xiaoguang [2 ]
Liu, Yan [1 ]
Tong, Tong [1 ]
Xu, Hongmeng [1 ]
Jia, Li [1 ]
机构
[1] Fourth Hosp Hebei Med Univ, Dept Anesthesiol, Shijiazhuang 050000, Hebei, Peoples R China
[2] Fourth Hosp Hebei Med Univ, Dept Radiol, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China
关键词
anesthetic agents; inflammation; Caco-2; HK-2; HepG2;
D O I
10.3892/etm.2021.9918
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Anesthetic agents are often used in surgical procedures to relieve pain in patients with traumatic injuries. Several anesthetic agents can cause immunosuppression by suppressing the secretion of immune factors such as cytokines. However, the effects of different anesthetic agents on inflammation are not completely understood. In the present study, three cell lines, Caco-2, HK-2 and HepG2, were treated with five anesthetic agents, including sodium barbiturate, midazolam, etomidate, ketamine and propofol, to investigate the effects of different anesthetic agents on inflammation in in vitro models. The expression levels of inflammatory genes, including NF-kappa B and its downstream cytokines, were detected via reverse transcription-quantitative PCR. The results indicated that anesthetic agents, including sodium barbiturate, ketamine and propofol, but not midazolam and etomidate, exerted significant inhibitory effects on NF-kappa B expression in the three different cell lines. Sodium barbiturate, ketamine and propofol also decreased the expression levels of the NF-kappa B downstream cytokines, including IL-1 beta and IL-18. Moreover, sodium barbiturate, ketamine and propofol reduced the effect of TNF-alpha on inflammatory activity in the three cell lines. The results of the present study may provide novel insight into the effects of anesthetic agents on inflammation and may aid with selecting the most appropriate anesthetic agent in surgical procedures.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells
    Allister, EM
    Pal, S
    Thomson, AM
    Helmerhorst, E
    Mamo, JCL
    JOURNAL OF BIOMEDICAL SCIENCE, 2004, 11 (06) : 789 - 798
  • [22] CACO-2 CELLS: AN OVERVIEW
    Rao, A. Lakshmana
    Sankar, G. G.
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2009, 1 (02) : 260 - 275
  • [23] Effects of fatty acids on the growth of Caco-2 cells
    Nano, JL
    Nobili, C
    Girard-Pipau, F
    Rampal, P
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 69 (04): : 207 - 215
  • [24] Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells
    Ho, SS
    Pal, S
    ATHEROSCLEROSIS, 2005, 182 (01) : 29 - 36
  • [25] Effects of vipoxin and its components on HepG2 cells
    Doumanov, Jordan
    Mladenova, Kirilka
    Topouzova-Hristova, Tanya
    Stoitsova, Stoyanka
    Petrova, Svetla
    TOXICON, 2015, 94 : 36 - 44
  • [26] Cylindrospermopsin effects on protein profile of HepG2 cells
    Liebel, Samuel
    Grotzner, Sonia Regina
    Moura Costa, Daniele Dietrich
    Ferreira Randi, Marco Antonio
    de Oliveira Ribeiro, Ciro Alberto
    Filipak Neto, Francisco
    TOXICOLOGY MECHANISMS AND METHODS, 2016, 26 (07) : 554 - 563
  • [27] The effects of vitamin C on apoptosis in HepG2 cells
    Balkan, Burcu Menekse
    Sel, Tevhide
    ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI, 2014, 61 (04): : 237 - 241
  • [28] Apoptotic effects of insect tea in HepG2 human hepatoma cells
    Suo, Huayi
    Sun, Peng
    Wang, Cun
    Peng, Deguang
    Zhao, Xin
    CYTA-JOURNAL OF FOOD, 2016, 14 (02) : 169 - 175
  • [29] 36种蔬菜抑制肝癌HepG2和结肠腺癌Caco-2细胞增殖活性评价
    万红霞
    刘仁斌
    孙海燕
    刘冬
    食品与生物技术学报, 2015, (09) : 995 - 1001
  • [30] In Vitro Cytotoxicity and Oxidative Stress Evaluation of Valerian (Valeriana officinalis) Methanolic Extract in Hepg2 and Caco2 Cells
    Kara, Mehtap
    Alparslan, Ecem Dilara
    Oztas, Ezgi
    Erdogan, Ozlem Nazan
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 18 (05) : 604 - 608